Canine Aβ42 antibody and antigen (recombinant protein)

Diagnostic anti-Canine Aβ42 antibodies pairs and antigen for animal health (animal Dog/Canine Alzheimer Disease(AD)) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Companion Animal disease testing products collection >>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-CAN-AB42-Ag01Canine Aβ42$3090.00
GMP-CAN-AB42-Ab01Anti-Canine Aβ42 mouse monoclonal antibody (mAb)$3090.00
GMP-CAN-AB42-Ab02Anti-Canine Aβ42 mouse monoclonal antibody (mAb)$3090.00
GMP-CAN-AB42-Ab03Anti-Canine Aβ42 human monoclonal antibody (mAb)$3090.00
GMP-CAN-AB42-Ab04Anti-Canine Aβ42 human monoclonal antibody (mAb)$3090.00

Size: 1mg | 10mg | 100mg



Product Description

Cat No. GMP-CAN-AB42-Ag01
Product NameCanine Aβ42
Target/BiomarkerCanine Aβ42
Expression platformE.coli
IsotypesRecombinant Antigen
Bioactivity validationAnti-Canine Aβ42 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Aβ42 level test of animal Dog/Canine with Alzheimer Disease(AD).
TagHis
Reconized/Reactive SpecicsCanine Aβ42
Product descriptionRecombinant Canine Aβ42 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-CAN-AB42-Ab01,GMP-CAN-AB42-Ab02
Target/BiomarkerCanine Aβ42
Product NameAnti-Canine Aβ42 mouse monoclonal antibody (mAb)
Expression platformCHO
Isotypes Mouse IgG
Bioactivity validationRecombinant Canine Aβ42 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine Aβ42 antibodies in Canine Aβ42 level test of animal Dog/Canine with Alzheimer Disease(AD).
Product descriptionAnti-Canine Aβ42 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine Aβ42 antibodies.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-CAN-AB42-Ab03,GMP-CAN-AB42-Ab04
Target/BiomarkerCanine Aβ42
Product NameAnti-Canine Aβ42 human monoclonal antibody (mAb)
Expression platformCHO
IsotypesHuman lgG1
Bioactivity validationRecombinant Canine Aβ42 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine Aβ42 antibodies in Canine Aβ42 level test of animal Dog/Canine with Alzheimer Disease(AD).
Product descriptionAnti-Canine Aβ42 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker Information


    Measuring Canine Aβ42 levels is paramount in veterinary medicine and neuroscience. Aβ42 has emerged as a critical biomarker due to its direct involvement in the pathogenesis of neurodegenerative diseases in dogs.

    Elevated Aβ42 levels have been correlated with the severity of cognitive dysfunction in dogs. By quantifying Aβ42 in cerebrospinal fluid or brain tissue, veterinarians and researchers can gauge the extent of amyloid plaque formation and the associated neurotoxicity. This not only aids in early diagnosis but also offers an objective means of monitoring disease progression.

    Beyond diagnosis, Aβ42 measurements play a pivotal role in preclinical research and drug development. They provide a quantifiable endpoint for evaluating the effectiveness of potential therapeutic interventions. Whether it's the development of disease-modifying drugs or strategies to enhance cognitive function in dogs, Aβ42 serves as a crucial indicator of treatment efficacy.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.